Search This Blog

Sunday, November 8, 2015

Lilly and Incyte Announce Patients Treated with Baricitinib Demonstrated Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis Compared with Methotrexate (NYSE:LLY)

Lilly and Incyte Announce Patients Treated with Baricitinib Demonstrated Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis Compared with Methotrexate (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.